Search Results

You searched for : HSCT

	Startups that make life of Thalassemia patients easier â€“ Special Feature on World Thalassemia Day - 8th May Thalassemia is a preventable genetic blood disorder in which the patient's body cannot make sufficient red blood cells (RBC) on its own and require ... May 07
	Lupin Launches Posaconazole Delayed-Release Tablets Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA... Feb 17
	First Clinical Data from Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT) Orca Bio, today announced the first clinical data from its first-generation investigational therapy,... Dec 07
	New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-... Dec 04
	Merck received US FDA approval for Keytruda FDA approves expanded indication for Merckâ€™s KEYTRUDA (pembrolizumab) in adult patients with relapsed or refractory classical hodgkin lymphoma (cHL) ... Oct 16
	FDA Approves Expanded Indication for Merckâ€™s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL) ... Oct 15
	Stem Cell therapy has long lasting Neurological benefits Researchers show that stem cell therapy has a better and long-lasting effect on Neurological disorders.... Mar 19
7 Matching result(s) found!

-Advertisements-

Trending Now
	Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
	Akshay Tritiya Parna Mahotsav heldMay 16, 2024
	IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
	Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
	India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
	The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
	Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
	AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024
	Kamineni Doctors Successfully Remove Bone Stuck Near Heart in Elderly PatientMay 14, 2024
	On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology NursesMay 14, 2024
	Shiprocket announces Shiprocket Growth Academy to upskill 100,000 Indian MSMEs through eCommerce learningMay 14, 2024
	5 baby essential gifts for new and expecting momsMay 13, 2024
	BLUM India launches its first State-of-the-Art Experience Centre in HyderabadMay 13, 2024
	Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in IndiaMay 13, 2024
	Setback for Organ Transplantion: First Human to Receive Pig Kidney DiesMay 13, 2024
	Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024
	Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
	The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
	Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
	Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024

Search Results

Startups that make life of Thalassemia patients easier â€“ Special Feature on World Thalassemia Day - 8th May

Lupin Launches Posaconazole Delayed-Release Tablets

First Clinical Data from Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT)

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

Merck received US FDA approval for Keytruda

FDA Approves Expanded Indication for Merckâ€™s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL)

Stem Cell therapy has long lasting Neurological benefits

Trending Now